Revance Therapeutics Balance Sheet Health
Financial Health criteria checks 1/6
Revance Therapeutics has a total shareholder equity of $-151.6M and total debt of $429.1M, which brings its debt-to-equity ratio to -283%. Its total assets and total liabilities are $478.5M and $630.1M respectively.
Key information
-283.0%
Debt to equity ratio
US$429.10m
Debt
| Interest coverage ratio | n/a |
| Cash | US$253.92m |
| Equity | -US$151.60m |
| Total liabilities | US$630.06m |
| Total assets | US$478.45m |
Recent financial health updates
Here's Why Revance Therapeutics (NASDAQ:RVNC) Can Afford Some Debt
Aug 10
Does Revance Therapeutics (NASDAQ:RVNC) Have A Healthy Balance Sheet?
Apr 17Revance Therapeutics (NASDAQ:RVNC) Is Making Moderate Use Of Debt
Jan 02Does Revance Therapeutics (NASDAQ:RVNC) Have A Healthy Balance Sheet?
Aug 04Revance Therapeutics (NASDAQ:RVNC) Is Making Moderate Use Of Debt
Apr 17Recent updates
What Revance Therapeutics, Inc.'s (NASDAQ:RVNC) 30% Share Price Gain Is Not Telling You
Mar 04Revance: Stock Bouncing On Q4 Earnings, But Long-Term Challenges Remain
Feb 29Revenues Not Telling The Story For Revance Therapeutics, Inc. (NASDAQ:RVNC) After Shares Rise 27%
Dec 28Analysts Are More Bearish On Revance Therapeutics, Inc. (NASDAQ:RVNC) Than They Used To Be
Nov 10Here's Why Revance Therapeutics (NASDAQ:RVNC) Can Afford Some Debt
Aug 10Revance Therapeutics, Inc.'s (NASDAQ:RVNC) Earnings Haven't Escaped The Attention Of Investors
Jun 14Does Revance Therapeutics (NASDAQ:RVNC) Have A Healthy Balance Sheet?
Apr 17Revance Therapeutics (NASDAQ:RVNC) Is Making Moderate Use Of Debt
Jan 02Revance Therapeutics submits sBLA for Daxxify for cervical dystonia
Oct 20Revance climbs 14% as FDA approves facial injectable for frown lines
Sep 08Revance Therapeutics: More Risk To Sept. 8 PDUFA Than It Seems
Aug 24Does Revance Therapeutics (NASDAQ:RVNC) Have A Healthy Balance Sheet?
Aug 04Revance: Potential Comeback On FDA Resubmission For DAXI
Jul 15Revance Therapeutics (NASDAQ:RVNC) Is Making Moderate Use Of Debt
Apr 17Financial Position Analysis
Short Term Liabilities: RVNC has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: RVNC has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: RVNC has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: RVNC's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RVNC has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if RVNC has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.